ArticleAnnals of translational medicine2019

Impact of the 21-gene recurrence score assay on chemotherapy decision making and outcomes for breast cancer patients with four or more positive lymph nodes.

Qing-Hong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.